Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (121-130 of 381) with videos related to

Pageof 39
Sort By:
Journal of Clinical Medicine|February 25, 2022
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-AnalysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
European Urology|May 12, 2023
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital TumoursValentina Tateo, Veronica Mollica, Alessandro Rizzo, et al.
Expert Review of Gastroenterology & Hepatology|August 27, 2021
Radiofrequency ablation for intrahepatic cholangiocarcinoma: a tool upon the path of integrative modalities?Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Expert Review of Gastroenterology & Hepatology|September 23, 2021
Toward personalized therapy for cholangiocarcinoma: new insights and challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 10, 2006
Dynamical network model of infective mobile agentsMattia Frasca, Arturo Buscarino, Alessandro Rizzo, et al.
Cancers|February 12, 2021
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)Alessandro Rizzo, Maria Abbondanza Pantaleo, Annalisa Astolfi, et al.
Expert Review of Gastroenterology & Hepatology|March 18, 2022
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, et al.
Journal of Clinical Medicine|August 12, 2022
Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-AnalysisMatteo Righini, Veronica Mollica, Alessandro Rizzo, et al.
Anti-Cancer Drugs|July 7, 2021
Role of PD-L1 assessment in advanced NSCLC: does it still matter?Alessandro Rizzo, Filippo Gustavo Dall'Olio, Annalisa Altimari, et al.
Physical Review. E|November 28, 2019
Backbone reconstruction in temporal networks from epidemic dataFrancesco Vincenzo Surano, Christian Bongiorno, Lorenzo Zino, et al.
Pageof 39

Showing results (121-130 of 381) with videos related to

Sort By:
Pageof 39
Journal of Clinical Medicine|February 25, 2022
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-AnalysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
European Urology|May 12, 2023
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital TumoursValentina Tateo, Veronica Mollica, Alessandro Rizzo, et al.
Expert Review of Gastroenterology & Hepatology|August 27, 2021
Radiofrequency ablation for intrahepatic cholangiocarcinoma: a tool upon the path of integrative modalities?Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Expert Review of Gastroenterology & Hepatology|September 23, 2021
Toward personalized therapy for cholangiocarcinoma: new insights and challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|October 10, 2006
Dynamical network model of infective mobile agentsMattia Frasca, Arturo Buscarino, Alessandro Rizzo, et al.
Cancers|February 12, 2021
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)Alessandro Rizzo, Maria Abbondanza Pantaleo, Annalisa Astolfi, et al.
Expert Review of Gastroenterology & Hepatology|March 18, 2022
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, et al.
Journal of Clinical Medicine|August 12, 2022
Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-AnalysisMatteo Righini, Veronica Mollica, Alessandro Rizzo, et al.
Anti-Cancer Drugs|July 7, 2021
Role of PD-L1 assessment in advanced NSCLC: does it still matter?Alessandro Rizzo, Filippo Gustavo Dall'Olio, Annalisa Altimari, et al.
Physical Review. E|November 28, 2019
Backbone reconstruction in temporal networks from epidemic dataFrancesco Vincenzo Surano, Christian Bongiorno, Lorenzo Zino, et al.
Pageof 39